|
Heleen Roose1; Kristina Rekstyte-Matiene1; Sarah K Stevens2; Kusum Gupta3; Sandra Chang2; Cheng Liu2; Vladimir Serebryany2; Lillian Adame2; Kha Le2; Antitsa Stoycheva2; Lawrence M. Blatt2; Leonid N. Beigelman2; Sushmita Chanda2; David B. Smith2; Julian Symons2; Andreas Jekle2,4; Tongfei Wu1; 1Aligos Belgium BV, Leuven, Belgium; 2Aligos Therapeutics, Inc., South San Francisco, CA, USA; 3Aligos Therapeutics, Inc.; 4Aligos Therapeutics, Inc., South San Francisco, CA, USA, South San Francisco, CA, United States
|